News
Elicio Therapeutics To Present Updated Clinical T Cell And Antigen Spreading Response Data From The Ongoing AMPLIFY-201 Phase 1 Study Of ELI-002 And Preclinical Data On ELI-007 And ELI-008 At The AACR Annual Meeting
5 Apr 24
Biotech, News, General
12 Health Care Stocks Moving In Friday's After-Market Session
5 Apr 24
Movers
12 Health Care Stocks Moving In Monday's Intraday Session
18 Mar 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
8 Feb 24
Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 Feb 24
Movers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
7 Feb 24
Movers
Press releases
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
25 Apr 24
News, Press Releases
Elicio Therapeutics Celebrates 13 Years Developing Innovative Cancer Immunotherapies
24 Apr 24
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
11 Apr 24
Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
5 Apr 24
News, Press Releases
Unlocking the Power of Immunotherapy: Elicio Therapeutics' (NASDAQ: ELTX) Novel AMP Platform
5 Apr 24
Unlocking the Power of Immunotherapy: Elicio Therapeutics' (NASDAQ: ELTX) Novel AMP Platform
5 Apr 24
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
6 Feb 24
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
5 Feb 24
News, Press Releases
First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P
1 Feb 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002
30 Jan 24